Cancer Rop Co. Ltd. (KQ:180400) — Market Cap & Net Worth
Market Cap & Net Worth: Cancer Rop Co. Ltd. (180400)
Cancer Rop Co. Ltd. (KQ:180400) has a market capitalization of $155.09 Million (₩228.85 Billion) as of September 7, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #17640 globally and #733 in its home market, demonstrating a -9.71% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cancer Rop Co. Ltd.'s stock price ₩2325.00 by its total outstanding shares 98428696 (98.43 Million). Also see 180400 current and non-current assets for a full breakdown of the balance sheet.
Cancer Rop Co. Ltd. Market Cap History: 2026 to 2026
Cancer Rop Co. Ltd.'s market capitalization history from 2026 to 2026. Data shows growth from $155.09 Million to $155.09 Million (0.00% CAGR). Also see Cancer Rop Co. Ltd. cash flow conversion for how efficiently the company converts equity into cash flow.
Cancer Rop Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cancer Rop Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest Cancer Rop Co. Ltd. stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 180400 by Market Capitalization
Companies near Cancer Rop Co. Ltd. in the global market cap rankings as of September 7, 2026. Review Cancer Rop Co. Ltd. (180400) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Cancer Rop Co. Ltd. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #88 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #163 globally with a market cap of $146.68 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #492 globally with a market cap of $55.67 Billion USD ( CN¥380.46 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #602 globally with a market cap of $45.89 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $613.78 |
| #163 | Danaher Corporation | NYSE:DHR | $146.68 Billion | $207.66 |
| #492 | WuXi AppTec Co Ltd | SHG:603259 | $55.67 Billion | CN¥153.83 |
| #602 | Natera Inc | NASDAQ:NTRA | $45.89 Billion | $328.18 |
Cancer Rop Co. Ltd. Historical Marketcap From 2026 to 2026
Between 2026 and today, Cancer Rop Co. Ltd.'s market cap moved from $155.09 Million to $ 155.09 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩155.09 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 6th, 2026 the market cap of Cancer Rop Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $155.09 Million USD |
| MoneyControl | $155.09 Million USD |
| MarketWatch | $155.09 Million USD |
| marketcap.company | $155.09 Million USD |
| Reuters | $155.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cancer Rop Co. Ltd.
Dx & Vx Co., Ltd. engages in the development and sale of bio-health care products and provides molecular genetic testing services primarily in South Korea. The company offers healthcare products, including Ofmom Carefree, oat fermented food, and biocleaners; diagnostic products, comprising CLIDEX, precision diagnostics, and in vitro diagnostic kit; health check services; CDx development services;… Read more